ArticleTrials2025

How should overall survival be analysed in randomised clinical trials in cancer if participants receive subsequent treatment lines? A stakeholder consultation.

Kara-Louise Royle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.